Topic

Cigna

A collection of 1335 issues

How to Get Ocrevus (Ocrelizumab) Covered by Cigna in Ohio: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Ocrevus Covered by Cigna in Ohio Fastest path to approval: Submit Cigna's Ocrevus CCRD Prior Authorization Form via CoverMyMeds or fax (855) 840-1678. Include MS diagnosis (ICD-10), prior DMT failures, and clinical rationale. Standard review takes 5 business days; urgent cases call 800-882-4462. If denied,

Work With Your Doctor to Get Jaypirca (Pirtobrutinib) Approved by Cigna in North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Jaypirca (Pirtobrutinib) Covered by Cigna in North Carolina Cigna requires prior authorization for Jaypirca (pirtobrutinib), a specialty BTK inhibitor for relapsed mantle cell lymphoma or CLL/SLL after prior BTK inhibitor failure. Your doctor must submit clinical documentation proving prior therapy failures and medical necessity through Accredo

Get Emgality (galcanezumab-gnlm) Covered by Cigna in California: Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Emgality Covered by Cigna in California Yes, Cigna covers Emgality (galcanezumab-gnlm) for migraine prevention and episodic cluster headache, but requires prior authorization. Your doctor must document that you have ≥4 migraine days per month and have tried/failed at least 2 standard preventive medications. If denied, California

How to Get Pyrukynd (Mitapivat) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pyrukynd Covered by Cigna in Pennsylvania Cigna requires prior authorization for Pyrukynd (mitapivat) in Pennsylvania for adults with pyruvate kinase deficiency, confirmed by genetic testing (≥2 PKLR gene variants with ≥1 missense variant) and prescribed by a hematologist. You'll need hemoglobin ≤10 g/dL or

How to Get Kuvan (Sapropterin) Approved by Cigna in Illinois: Complete Timeline and Appeals Guide

Answer Box: Getting Kuvan Approved by Cigna in Illinois Cigna requires prior authorization for Kuvan (sapropterin) with approval typically taking 2-5 business days when complete documentation is submitted. Key requirements include: metabolic specialist prescription, confirmed PKU diagnosis with BH4 responsiveness testing showing ≥30% phenylalanine reduction, concurrent phenylalanine-restricted diet, and documented

Work With Your Doctor to Get Filspari (Sparsentan) Approved by Cigna in Illinois: Forms, Appeals, and Timeline

Answer Box: Getting Filspari Approved by Cigna in Illinois To get Filspari (sparsentan) covered by Cigna in Illinois, you need: (1) biopsy-proven IgA nephropathy with proteinuria ≥1.0 g/day and eGFR ≥30 mL/min, (2) documented failure/intolerance of maximized ACE inhibitor or ARB therapy for ≥90 days, and

Getting Zolgensma Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by Cigna in New Jersey Zolgensma (onasemnogene abeparvovec-xioi) requires prior authorization from Cigna but is covered as a one-time specialty medication. For fastest approval: 1) Submit PA with genetic confirmation (≤3 SMN2 copies), anti-AAV9 titer ≤1:50, and baseline labs through CoverMyMeds or Cigna provider

How to Get Rebif (Interferon Beta-1a) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Rebif Covered by Cigna in North Carolina Rebif (interferon beta-1a) requires prior authorization through Cigna's specialty pharmacy partner Accredo. Your neurologist must submit clinical documentation showing confirmed relapsing MS, recent MRI activity, and safety labs (CBC, liver function tests). If denied, you have 180 days

How to Get Jakafi (Ruxolitinib) Covered by Cigna in Texas: Forms, Appeals, and PA Requirements

Answer Box: Getting Jakafi (Ruxolitinib) Covered by Cigna in Texas Jakafi (ruxolitinib) requires prior authorization for Cigna coverage in Texas, listed as Tier 4 specialty with PA, quantity limits, and step requirements. For myelofibrosis, patients ≥18 years qualify; for polycythemia vera, prior hydroxyurea failure is required. Submit PA via CoverMyMeds,

How to Get Firazyr (Icatibant) Covered by Cigna in Washington: Appeals Process, Forms, and State Protections

Quick Answer: Getting Firazyr (Icatibant) Covered by Cigna in Washington Firazyr (icatibant) requires prior authorization from Cigna, typically managed through Express Scripts/Accredo. If denied, Washington residents have strong appeal rights: internal appeals within 180 days, followed by binding external review through an Independent Review Organization (IRO) within 120 days.